CYTO

Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)

Delisted

CYTO was delisted on the 19th of December, 2024.

10 hedge funds and large institutions have $37.1M invested in Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
Closed
Calls
$4K
Puts
Net Calls
+$4K
Net Calls Change
+$5K
Name Holding Trade Value Shares
Change
Shares
Change %
WA
1
Wasatch Advisors
Utah
$11.6M
BG
2
Bellevue Group
Switzerland
$9.09M
Fidelity Investments
3
Fidelity Investments
Massachusetts
$6.47M
RSCM
4
Rock Springs Capital Management
Maryland
$3.56M +$324K +1 +10%
TCM
5
Tekla Capital Management
Massachusetts
$3.5M
OM
6
Opaleye Management
Massachusetts
$1.43M
TAM
7
Tocqueville Asset Management
New York
$314K
AG
8
Advisor Group
Arizona
$277K +$277K +1 New
FO
9
FT Options
Illinois
$205K +$205K +1 New
KeyBank National Association
10
KeyBank National Association
Ohio
$183K
TC
11
TFS Capital
Pennsylvania
$160K -$118K
HCM
12
Harvey Capital Management
Florida
$136K -$136K
Geode Capital Management
13
Geode Capital Management
Massachusetts
$64K -$56
AC
14
Amici Capital
New York
$42K -$36K
UBS Group
15
UBS Group
Switzerland
$33K
Citigroup
16
Citigroup
New York
$8K -$7K
Morgan Stanley
17
Morgan Stanley
New York
$2K -$2K
HI
18
Hudock Inc
Pennsylvania
$1K -$1K
Simplex Trading
19
Simplex Trading
Illinois
-$1K
TRCT
20
Tower Research Capital (TRC)
New York
-$1K
VKH
21
Virtu KCG Holdings
New York
-$46K
AIG
22
American International Group
New York
-$13K
JPMorgan Chase & Co
23
JPMorgan Chase & Co
New York
-$5K
Goldman Sachs
24
Goldman Sachs
New York
-$90K
ZIM
25
Zacks Investment Management
Illinois
-$86K